Seeing Is Believing
Currently out of the existing stock ratings of Charles Pitman, 2 are a HOLD (100%).
Analyst Charles Pitman, currently employed at BARCLAYS, carries an average stock price target met ratio of 50% that have a potential upside of 23.7% achieved within 284 days.
Charles Pitman’s has documented 4 price targets and ratings displayed on 1 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on ARGX, argenx NV ADR at 24-Sep-2021.
Analyst best performing recommendations are on ARGX (ARGENX NV ADR).
The best stock recommendation documented was for ARGX (ARGENX NV ADR) at 9/24/2021. The price target of $381 was fulfilled within 284 days with a profit of $73 (23.7%) receiving and performance score of 0.83.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
640
$122.68 (23.71%)
500
8 days ago
9/12 (75%)
$123.31 (23.87%)
210
Hold
25 days ago
6/8 (75%)
$93.88 (19.07%)
89
Buy
515
$-2.32 (-0.45%)
490
1 months 2 days ago
8/9 (88.89%)
$15.95 (3.20%)
133
Buy
560
$42.68 (8.25%)
519
1 months 5 days ago
13/15 (86.67%)
$65.54 (13.25%)
103
Buy
585
$67.68 (13.08%)
430
1 months 5 days ago
8/10 (80%)
$90.54 (18.31%)
149
What Year was the first public recommendation made by Charles Pitman?